Skip to main content

MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3

Buy Article:

$42.00 + tax (Refund Policy)

MicroRNAs (miRNAs or miRs), a group of small non-coding RNAs, have been demonstrated to play key roles in various physicological processes and diseases, including diabetes, the most common metabolic disorder. However, the underlying mechanisms remains largely unknown. In this study, we aimed to investigate the role of miR19a3p in diabetes. The results of RT-qPCR demonstrated that the level of miR19a3p was significantly decreased in the diabetic patients, and that the decreased miR50a-5p level was significantly associated with a high concentration of blood glucose. miR19a3p mimic was further used to transfect pancreatic β cells, and we found that the overexpression of miR-19a-3p promoted cell proliferation and insulin secretion, while it suppressed the apoptosis of pancreatic β cells. Suppressor of cytokine signaling 3 (SOCS3) was further identified as a direct target gene of miR19a3p, and its protein level was significantly decreased following the overexpression of miR19a3p. Moreover, the siRNA-induced downregulation of SOCS3 also enhanced cell proliferation and insulin secretion, while it inhibited the apoptosis of pancreatic β cells. In addition, the overexpression of SOCS3 reversed the effects of miR19a3p overexpression on cell proliferation, insulin secretion and on the apoptosis of pancreatic β cells, which further indicates that SOCS3 acts as a downstream effector in the miR-19a-3p-mediated function of pancreatic β cells. Finally, the level of SOCS3 was increased in diabetic patients, and inversely correlated with the miR19a3p level, suggesting that the downregulation of miR-19a-3p leads to the upregulation of SOCS3, which contributes to the dysfunction of pancreatic β cells. On the whole, the findings of this study suggest that miR19a3p plays an important role in β cell function, and that the miR-19a-3p/SOCS3 axis may become a potential therapeutic target for diabetes.

Document Type: Research Article

Affiliations: Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 410000, P.R. China

Publication date: 01 January 2016

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content